Evidence map›Paper›PMID 38313054›Full record

ArticleiScience2024

EBAG9-deficient mice display decreased bone mineral density with suppressed autophagy.

Kotaro Azuma, Kazuhiro Ikeda, Sachiko Shiba, Wataru Sato, Kuniko Horie, Tomoka Hasegawa, Norio Amizuka, Shinya Tanaka, Satoshi Inoue

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kotaro AzumaDepartment of Systems Aging Science and Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi-ku, Tokyo 173-0015, Japan.
Kazuhiro IkedaDivision of Systems Medicine and Gene Therapy, Saitama Medical University, Hidaka, Saitama 350-1241, Japan.
Sachiko ShibaDivision of Systems Medicine and Gene Therapy, Saitama Medical University, Hidaka, Saitama 350-1241, Japan.
Wataru SatoDivision of Systems Medicine and Gene Therapy, Saitama Medical University, Hidaka, Saitama 350-1241, Japan.
Kuniko HorieDivision of Systems Medicine and Gene Therapy, Saitama Medical University, Hidaka, Saitama 350-1241, Japan.
Tomoka HasegawaDepartment of Developmental Biology of Hard Tissue, Graduate School of Dental Medicine, Hokkaido University, Sapporo, Hokkaido 060-8586, Japan.
Norio AmizukaDepartment of Developmental Biology of Hard Tissue, Graduate School of Dental Medicine, Hokkaido University, Sapporo, Hokkaido 060-8586, Japan.
Shinya TanakaDepartment of Orthopedic Surgery, Saitama Medical University, Moroyama, Saitama 350-0495, Japan.
Satoshi InoueDepartment of Systems Aging Science and Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi-ku, Tokyo 173-0015, Japan.
Saitama Medical University · JPHokkaido University · JPTokyo Metropolitan Institute of Gerontology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Estrogen receptor-binding fragment associated antigen 9 (EBAG9) exerts tumor-promoting effects by inducing immune escape. We focused on the physiological functions of EBAG9 by investigating the bone phenotypes of

Indexed as

Biological sciencesCell biologyMolecular biologyOrthopedics

Identifiers

PMID38313054
PMCPMC10835455
OpenAlexW4390739030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.